ALI ALEDHAIM: Open Payments
NPI 1487350039 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,455 in 78 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,211 · 2025 $2,455
Food & beverage: $2,455
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 10 | $830 |
| Novo Nordisk Inc | 12 | $361 |
| SCPHARMACEUTICALS INC. | 7 | $279 |
| E.R. Squibb & Sons, L.L.C. | 13 | $217 |
| Lilly USA, LLC | 5 | $124 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $91 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $82 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $70 |
| Esperion Therapeutics, Inc. | 3 | $64 |
| PFIZER INC. | 3 | $58 |
Products named: Assure WCD, FUROSCIX, Wegovy, Ozempic, CAMZYOS, ELIQUIS, JARDIANCE, LifeVest.
Industry payments across MD — which companies pay providers there.
